- The maximum number of patients on the phase I portion of the trial is 30 and the two cohorts in phase II may accrue up to 20 evaluable patients each. Thus, the maximum number of evaluable patients who may enroll on this trial is 70. In order to allow for a small number of in-evaluable patients, the accrual ceiling will be set at 75.